Eric Drape - 08 Feb 2022 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Reporting relationship: Executive VP Global Operations
Issuer ticker: TEVA
Reported as of: 08 Feb 2022
Net transaction value: -$32,464
SEC form: 4
Accepted by SEC: 10 Feb 2022, 15:08:25 UTC
Prior SEC filing: 25 May 2021
Next SEC filing: 02 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Dov Bergwerk as attorney-in-fact for Eric Drape

Key filing fact

Eric Drape filed Form 4 for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) on 10 Feb 2022.

Key facts

This page summarizes Eric Drape's Form 4 filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 10 Feb 2022, 15:08.

Change

Previous filing in this sequence was filed on 25 May 2021.
Current net transaction value: -$32,464.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TEVA transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +6,568
Change %: +20%
Price
Shares after: 39,696
Date: 09 Feb 2022
Ownership: Direct
Footnotes: F1, F2

TEVA transaction

Ordinary Shares

Sale

Transaction value: $32,464
Shares: -3,583
Change %: -9%
Price: $9.06
Shares after: 36,113
Date: 09 Feb 2022
Ownership: Direct
Footnotes: F1, F3, F4, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TEVA transaction Derivative

Restricted Share Units

Options Exercise

Transaction value: $0
Shares: -6,568
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 09 Feb 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 6,568
Exercise price
Footnotes: F2, F6

TEVA transaction Derivative

Restricted Share Units

Award

Transaction value: $0
Shares: +32,518
Change %
Price: $0.000000
Shares after: 32,518
Date: 08 Feb 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 32,518
Exercise price
Footnotes: F2, F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Footnote F2

Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.

Footnote F3

The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Footnote F4

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II.

Footnote F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.06 to $9.075, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F6

Restricted share units were granted on February 9, 2018, with 6,567 having vested on each of February 9, 2020 and February 9, 2021 and 6,568 having vested on February 9, 2022.

Footnote F7

Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 4, 2022.